United States  
 

Trusted News Discovery Since 2008		One News Page

Remdesivir

Antiviral drug

Remdesivir    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Remdesivir: Antiviral drug
Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the 2020 COVID-19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in around 50 countries. Updated guidelines from the World Health Organization in November 2020 include a conditional recommendation against the use of remdesivir for the treatment of COVID-19.

0
shares		ShareTweetSavePostSend
 

The WHO No Longer Recommends Remdesivir For COVID-19 Patients [Video]

The WHO No Longer Recommends Remdesivir For COVID-19 Patients

The FDA approved remdesivir as a treatment for severe COVID-19 cases last month. This is after granting emergency authorization in May, reports Business Insider. But on Thursday, the WHO announced it..

Credit: Wochit News     Duration: 00:39Published
FDA Approves Remdesivir to Treat COVID-19 [Video]

FDA Approves Remdesivir to Treat COVID-19

US regulators have approved the use of remdesivir, an antiviral medicine, for COVID-19 treatment.

Credit: Cover Video STUDIO     Duration: 01:20Published
Remdesivir has little effect on COVID deaths: WHO [Video]

Remdesivir has little effect on COVID deaths: WHO

Anti-viral medication remdesivir was found to have little or no effect on COVID-19 patients' length of hospital stay or chances of survival, according to a clinical trial by the World Health..

Credit: Reuters Studio     Duration: 01:36Published
COVID-19: Indian American Trump supporters outside Walter Reed Hospital call for prayers as President is being treated [Video]

COVID-19: Indian American Trump supporters outside Walter Reed Hospital call for prayers as President is being treated

A prayer vigil was held on Sunday evening for President Trump and First Lady Melania Trump by the Indian American community to wish them a speedy recovery. His supporters not only gathered outside the..

Credit: ANI     Duration: 02:59Published

You Might Like


World Health Organization Rejects Antiviral Drug Remdesivir as Covid-19 Treatment

In a review of several trials, the World Health Organization found that Gilead’s drug did not improve survival rates for patients nor did it help them recover.
NYTimes.com - Published

F.D.A. Approves Remdesivir as First Drug to Treat Covid-19

The move indicated that the drug had cleared more rigorous hurdles since it was given emergency authorization in May.
NYTimes.com - Published Also reported by •Reuters

WHO study shows Remdesivir does little to prevent COVID-19 deaths

The antiviral drug has been considered one of the most promising COVID-19 treatments and was among those given to President Trump when he was hospitalized for coronavirus treatment.
CBS News - Published

Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial

An antiviral widely used to treat hospitalized patients did not lower the mortality rate in a multinational trial.
NYTimes.com - Published

President Trump’s COVID-19 treatment is usually reserved for more serious patients

President Trump has been treated with Remdesivir, the steroid Dexamethasone, and an experimental antibody therapy since testing positive for COVID-19. Some experts say those drugs are usually reserved..
CBS News - Published

Trump COVID-19 treatment: President had stakes in Regeneron and Gilead, makers of antibody cocktail, Remdesivir

President Trump previously reported he earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences Inc., makers of COVID-19 treatments.
USATODAY.com - Published

New report blames administration mismanagement, Gilead monopoly for shortages of COVID-19 drug

A new report says some hospitals around the country did not get enough of a critical drug used for COVID-19 patients. The FDA approved the drug, Remdesivir, for emergency use in May. But the report..
CBS News - Published

Remdesivir and COVID-19: New data suggests the experimental drug can shorten how long people are sick

According to new results from Gilead, new data shows 74% of patients treated with remdesivir had recovered by their 14th day of hospitalization.
USATODAY.com - Published

Remdesivir, the First Coronavirus Drug, Gets a Price Tag

Federal health officials and Gilead Sciences have settled on priority distribution to Americans — and nonnegotiable pricing.
NYTimes.com - Published

Fact check: China doesn't own patent for coronavirus treatment remdesivir

A viral claim that China owns remdesivir's patent through an agreement with a multi-national public health organization called Unitaid is false.
USATODAY.com - Published

Haphazard Rollout of Coronavirus Drug Frustrates Doctors

Remdesivir was shipped to small hospitals even as besieged medical centers were denied access.
NYTimes.com - Published

How Remdesivir, New Hope for Covid-19 Patients, Was Resurrected

The drug failed as a treatment for hepatitis and Ebola. With federal funding, scientists trained it on the coronavirus.
NYTimes.com - Published

Your Thursday Briefing

Coronavirus, Remdesivir, Unemployment: Here’s what you need to know.
NYTimes.com - Published

Gilead Claims ‘Positive Data’ to Come From N.I.H. Trial of Remdesivir

Neither the company nor the institutes discussed the data. Previous results for the potential coronavirus treatment have been inconclusive.
NYTimes.com - Published

What is remdesivir? Gilead Sciences drug reportedly shows promise treating coronavirus

Remdesivir, a Gilead Sciences antiviral drug, is reportedly showing promise for the treatment of the coronavirus in clinical trials.
USATODAY.com - Published